Which are the causes of Retinopathy Of Prematurity?

Retinopathy of Prematurity (ROP) is a condition primarily caused by the abnormal development of retinal blood vessels in premature infants, triggered by the disruption of normal eye growth following early birth. While the exact etiology involves a complex interplay between oxygen exposure and developmental maturity, it is categorized as a multifactorial condition rather than a single genetic disorder.

What causes Retinopathy of Prematurity?

The primary cause of Retinopathy of Prematurity is the interruption of normal retinal vascularization. In a full-term pregnancy, blood vessels grow from the center of the retina outward to the edges. When a baby is born very prematurely, this process is incomplete. Exposure to the outside environment, particularly fluctuating oxygen levels, disrupts the signaling proteins (like VEGF) that guide vessel growth, causing them to grow in a disorganized or "leaky" fashion.

Are there genetic factors linked to Retinopathy of Prematurity?

While Retinopathy of Prematurity is not a simple inherited disease, research suggests that genetic predisposition plays a significant role in why some infants develop severe disease while others with similar clinical profiles do not. Current studies are investigating variations in genes related to oxygen sensing and vascular growth, such as FZD4, LRP5, and VEGF, which may influence an infant's susceptibility.

What are the primary risk factors?

It is vital to distinguish between a "cause" (the biological mechanism) and a "risk factor" (the clinical situation). The following factors significantly increase the likelihood of developing Retinopathy of Prematurity:

• Low birth weight: Infants weighing less than 1,500 grams are at significantly higher risk.


• Gestational age: Birth before 30 weeks of gestation is a primary clinical predictor.


• Oxygen therapy: High or fluctuating levels of supplemental oxygen can impact vessel development.


• Systemic illness: Conditions such as sepsis, respiratory distress syndrome, or blood transfusions can exacerbate the disease.

What is the current state of research?

Medical researchers are actively working to better understand the molecular triggers of Retinopathy of Prematurity. Current clinical trials are exploring targeted therapies to normalize vessel growth and using artificial intelligence for more precise screening. As of today, 15 members of the DiseaseMaps.org community have shared their experiences with Retinopathy of Prematurity, helping researchers better understand the long-term outcomes of this condition.

Next steps

• Consult a pediatric ophthalmologist for regular retinal screenings if your child was born prematurely.


• Monitor for signs of vision changes, such as poor fixation or unusual eye movements.


• Join the Retinopathy of Prematurity community at DiseaseMaps.org to connect with other families.


• Discuss the latest advancements in anti-VEGF therapies with your clinical care team.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Retinopathy of Prematurity


• Orphanet: Retinopathy of prematurity (ORPHA: 79268)


• National Eye Institute (NEI): Facts About Retinopathy of Prematurity


• American Academy of Pediatrics (AAP) Guidelines on ROP screening